PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program

By afschroeder • February 13, 2026

Kimura K, Murthy V, Voter AF, Solnes LB, Moradi Tuchayi A, Yadav S, Theus L, Nguyen A, Ludwig V, Holzgreve A, Unterrainer LM, Grogan TR, Czernin J, Hope TA, Gafita A, Calais J. PSMA PET/CT-Derived Indicators and Outcomes After [¹⁷⁷Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program. J Nucl Med. 2026 Feb 12:jnumed.125.270789. doi: 10.2967/jnumed.125.270789. Epub ahead of print. PMID: 41679922.

Tags: 177Lu-PSMA, Cardiology/Epi, DOM STAT, General Internal Medicine, imaging biomarker, metastatic castration-resistant prostate cancer, PSMA PET/CT, Publications, SUVmean

Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing

Lee Y, Feng J, Rahrooh A, Bui AAT, Cooper CB, Hsu JJ. Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing.[...]

Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic Sclerosis

Delgadillo R, Roufeh E, Lavelle B, Nguyen K, de la Rosa A. Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic[...]

A contemporary review on heart failure with improved ejection fraction

Weiss A, Flowers A, Eisenberg SD, Wu L, Rodriguez M, Khawaja M, Moras E, Lavie CJ, Fonarow GC, Tang WHW, Bozkurt B, Krittanawong C. A[...]